Disclosure Of First-Time Adoption [Text Block]

ABIVAX - Filing #2810976

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
196 010 EUR
135 209 EUR
147 740 EUR
478 218 EUR
629,000 EUR
112,000 EUR
82 770 EUR
60 740 EUR
150 476 EUR
223,000 EUR
EUR
7 189 EUR
42 452 EUR
25 934 EUR
39 361 EUR
25 934 EUR
107 578 EUR
EUR
168,000 EUR
1 733 EUR
143,000 EUR
EUR
2 851 EUR
37 633 EUR
42 073 EUR
Comprehensive income
147 516 EUR
147 740 EUR
112,000 EUR
147 516 EUR
EUR
112,000 EUR
EUR
EUR
60 506 EUR
235,000 EUR
60 740 EUR
EUR
EUR
42 452 EUR
169,000 EUR
42 283 EUR
Profit (loss)
147 740 EUR
147 740 EUR
EUR
EUR
EUR
EUR
EUR
60 740 EUR
EUR
60 740 EUR
60 740 EUR
EUR
EUR
42 452 EUR
EUR
42 452 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.